![semaglutide tirzepatide news today recency 3 Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs Endocrinology Obesity articles page [12]](https://www.wric.com/wp-content/uploads/sites/74/2025/05/68211f323c0d53.25928951.jpeg?w=2560&h=1440&crop=1)
semaglutide tirzepatide news today recency 3 Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs Endocrinology Obesity articles page [12]
USD28.14
USD63.14
Pay in 4 interest-free payments of $7.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
![semaglutide tirzepatide news today recency 3 Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs Endocrinology Obesity articles page [12]](https://assets.medpagetoday.net/media/images/110xxx/110999_m.jpg)
![semaglutide tirzepatide news today recency 3 Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs Endocrinology Obesity articles page [12]](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3906465635147443965)
![semaglutide tirzepatide news today recency 3 Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs Endocrinology Obesity articles page [12]](https://femmeaesthetics.com/images/blog/tirzepatide-vs-semaglutide.webp)
![semaglutide tirzepatide news today recency 3 Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs Endocrinology Obesity articles page [12]](https://www.clinicalnutritioncenter.com/wp-content/uploads/2024/04/semaglutide-vs-tirzepatide-weight-loss.png)
![semaglutide tirzepatide news today recency 3 Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs Endocrinology Obesity articles page [12]](https://www.news-medical.net/images/news/ImageForNews_823661_1762823702430930.png)
.jpg)
